SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
STRATA Skin Sciences, Inc. (SSKN) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 28/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SSKN
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.18
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.35
Book Value / Share$0.00
Revenue / Share$0.66
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-14.40 |
$31.76M |
$-3.34M |
-10.5% |
| 2017 |
$-32.60 |
$31.45M |
$-21.51M |
-68.4% |
| 2018 |
$-1.48 |
$29.86M |
$-4.03M |
-13.5% |
| 2019 |
$-1.18 |
$31.59M |
$-3.79M |
-12% |
| 2020 |
$-1.31 |
$23.09M |
$-4.41M |
-19.1% |
| 2021 |
$-0.79 |
$29.98M |
$-2.71M |
-9% |
| 2022 |
$-1.60 |
$36.16M |
$-5.55M |
-15.3% |
| 2023 |
$-3.10 |
$33.36M |
$-10.83M |
-32.5% |
| 2024 |
$-2.65 |
$33.56M |
$-10.09M |
-30.1% |
| 2025 |
$-1.35 |
$30.7M |
$-6.26M |
-20.4% |
